<DOC>
	<DOC>NCT00223080</DOC>
	<brief_summary>The purpose of this study is to determine whether immunizations with an integrated combination of ALVAC-HIV (vCP1521) boosted by AIDSVAX gp120 B/E prevent HIV infection in healthy Thai volunteers.</brief_summary>
	<brief_title>HIV Vaccine Trial in Thai Adults</brief_title>
	<detailed_description>A vaccine for the prevention of HIV infection remains an urgent need as part of the efforts to control the HIV pandemic. In this phase III efficacy trial, a 'prime-boost' vaccine strategy is evaluated for prevention of infection and ameliorationn of disease course. ALVAC-HIV (vCP1521) from sanofi pasteur is given as the 'prime' vaccine at months 0, 1, 3 and 6; AIDSVAX gp120 B/E from VaxGen is given as the 'boost' at months 3 and 6. This regimen will be given to 8,000 adult Thai subjects, while another 8,000 will be given placebos in a double-blinded, randomized manner. Following the completion of each subjects immunization phase, he/she will be followed for 3 years with clinic visits every 6 months with HIV testing, pre- and post-test counseling. Subjects who become HIV infected will be counseled, referred to HIV treatment facilities for management according to national guidelines, and offered enrollment in a protocol for extended follow-up.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Thai citizen, 1830 years of age; either gender, Available for participation for 3.5 years, Able to understand study and give written informed consent, Completed enrollment in associated screening protocol HIV positive, Participant in previous HIV vaccine trial, Active TB or other systemic disease; immunodeficiency or chronic use of immune modifying therapy, History of anaphylaxis or other serious adverse reactions to vaccines, For women, breast feeding or pregnant (or planning to become pregnant during the first 9 months after enrollment)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>HIV Seronegativity</keyword>
</DOC>